MAPS:NASDAQWM Technology, Inc. Analysis
Data as of 2026-04-16 - not real-time
$0.39
Latest Price
8/10Risk
Risk Level: High
Executive Summary
WM Technology, Inc. (MAPS) is trading at roughly $0.39, dramatically below its DCF‑derived fair value of about $1.89, implying an upside of over 500% if the model holds. The stock is deeply oversold with an RSI of 27 and sits beneath its 20‑day, 50‑day and 200‑day moving averages, while the MACD remains in a bearish configuration, suggesting further short‑term downside pressure despite the support around $0.33. Revenue has fallen 9.7% YoY to $174.7 M and the average paying client base slipped 2% year‑over‑year, driven by pricing pressure in key markets such as California, Michigan and Oklahoma. Operating expenses rose modestly (2% YoY) and profit margins are thin at just over 1%, though gross margins remain exceptionally high at 95% and cash on hand ($62 M) comfortably exceeds debt ($26.5 M). Volatility is extreme (174% 30‑day) and the stock has experienced a 72% drawdown from its peak, underscoring significant price risk.
Despite these headwinds, MAPS trades at a forward PE of ~2.3, a price‑to‑book of 0.74 and a price‑to‑sales of 0.39, all well below the industry averages, indicating a strong value case. The balance sheet is solid with low leverage (debt‑to‑equity ~20%) and ample liquidity, and the company’s high‑margin SaaS platform offers a defensible recurring‑revenue model. However, the cannabis sector remains subject to high regulatory scrutiny and market‑specific pricing pressures, which could delay a revenue turnaround. Investors should weigh the massive valuation upside against the near‑term earnings weakness and sector risk when forming a position.
Despite these headwinds, MAPS trades at a forward PE of ~2.3, a price‑to‑book of 0.74 and a price‑to‑sales of 0.39, all well below the industry averages, indicating a strong value case. The balance sheet is solid with low leverage (debt‑to‑equity ~20%) and ample liquidity, and the company’s high‑margin SaaS platform offers a defensible recurring‑revenue model. However, the cannabis sector remains subject to high regulatory scrutiny and market‑specific pricing pressures, which could delay a revenue turnaround. Investors should weigh the massive valuation upside against the near‑term earnings weakness and sector risk when forming a position.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Oversold technical indicators (RSI 27, price below all SMAs)
- Revenue contraction and thin profit margin
- High short‑term volatility and proximity to support level
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Substantial valuation upside relative to DCF and peers
- Strong cash position and low leverage
- Uncertainty around client spend recovery and regulatory environment
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Large upside potential if DCF assumptions materialize
- High gross margins and scalable SaaS business model
- Improving industry fundamentals as cannabis markets mature
Key Metrics & Analysis
Financial Health
Revenue Growth-9.70%
Profit Margin1.12%
P/E Ratio19.3
ROE2.59%
ROA5.46%
Debt/Equity20.15
P/B Ratio0.7
Op. Cash Flow$26.2M
Free Cash Flow$21.5M
Industry P/E35.7
Technical Analysis
TrendBearish
RSI27.0
Support$0.33
Resistance$0.73
MA 20$0.57
MA 50$0.65
MA 200$0.91
MACDBearish
VolumeIncreasing
Fear & Greed Index88.98
Valuation
Fair Value$1.89
Target Price$2.61
Upside/Downside574.59%
GradeUndervalued
TypeValue
Risk Assessment
Beta0.65
Volatility174.43%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.